Search results for "Chronic kidney disease"


 
Results 31 - 40 of about 165 for "Chronic kidney disease".
Sort by: Relevance | Newest | Oldest

Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib

While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023

Inappropriate medications prescribed in some Medicare patients with CKD, study finds

Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021

MKSAP Quiz: Difficult-to-control hypertension

A 62-year-old man is evaluated during a follow-up visit for difficult-to-control hypertension. He also has chronic kidney disease and hyperlipidemia. Following a physical exam and lab studies, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2021/08/24/3.htm
24 Aug 2021

Meta-analysis compares mortality benefits of heart failure treatment combinations

Patients taking an angiotensin receptor-neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, and sodium-glucose cotransporter-2 inhibitor showed the greatest reduction in risk of death, the analysis of heart failure with reduced ejection fraction found.
https://immattersacp.org/weekly/archives/2021/12/14/4.htm
14 Dec 2021

GLP-1 receptor agonists may offer kidney protection in patients with type 2 diabetes

An industry-conducted pooled analysis of two large trials of glucagon-like peptide-1 (GLP-1) receptor agonists found that both semaglutide and liraglutide slowed kidney function decline, with semaglutide appearing to have the greatest effect.
https://immattersacp.org/weekly/archives/2021/12/21/2.htm
21 Dec 2021

Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide

Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020

Higher baclofen dosage associated with encephalopathy in older patients with CKD

A retrospective Canadian study compared 30-day risk for encephalopathy in older patients with chronic kidney disease (CKD) who were newly prescribed at least 20 mg of baclofen per day versus a lower dose, as well as in baclofen users versus nonusers.
https://immattersacp.org/weekly/archives/2019/11/12/4.htm
12 Nov 2019

Guideline issued on blood pressure management in CKD

The Kidney Disease: Improving Global Outcomes Work Group recommends targeting a standardized systolic blood pressure less than 120 mm Hg in patients with chronic kidney disease (CKD) who are not receiving dialysis, among other guidance.
https://immattersacp.org/weekly/archives/2021/06/22/4.htm
22 Jun 2021

Diltiazem may increase bleeding risk when coadministered with DOACs in afib

A study of patients with atrial fibrillation in one U.S. health system found a 56% higher risk for bleeding-related hospitalization associated with concomitant use of diltiazem and a direct-acting oral anticoagulant (DOAC) versus a DOAC alone.
https://immattersacp.org/weekly/archives/2022/07/12/5.htm
12 Jul 2022

MKSAP Quiz: Evaluation of gynecomastia

A 29-year-old man is evaluated for gynecomastia present for the past 2 years. He also has fatigue, low libido, weight gain, and erectile dysfunction. Following a physical exam, what is the most appropriate diagnostic test?
https://immattersacp.org/weekly/archives/2023/02/28/3.htm
28 Feb 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next